Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival.

Diabetes mellitus (DM) constitutes a major end-stage renal disease (ESRD) health problem. Glycemic control is fundamental to the management of diabetes and its complications, and relies on monitoring of hyperglycemia. We therefore performed a primary data analysis of glycemic control and survival on a large national ESRD database. Ninety-five percent of patients with DM had type II diabetes (N = 23,504), and five percent had type I diabetes (N = 1,371). For the combined population, the mean hemoglobin A1c (HgbA1c) was 6.77%, and the mean random blood glucose was 168 mg/dl. Mean HgbA1c values were >7.0% in 35% and >8.5% in 14%. Mean HgbA1c values were below 5% in 11.3% of patients. Type I study patients tended to have higher HgbA1c values. Most patients (75.8%) had three or more random blood glucose determinations within 90 days preceding the HgbA1c measurement. The HgbA1c showed only a weak correlation with mean random glucose values (R2 0.3716; s.e. = 1.36). The survival rates in the subsequent 12-month period ranged from 80 to 85% across different HgbA1c strata. Kaplan-Meier survival curves grouped by HgbA1c levels showed no correlation between HgbA1c and survival at 12 months. More studies are needed to refine recommendations for the role of HgbA1c and glycemic control in this patient population.

[1]  A. Sehgal,et al.  The provision and outcomes of diabetic care of hemodialysis patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  R. Gleason,et al.  Reproducibility of hemoglobin AIc and sensitivity to various degrees of glucose intolerance. , 1979, Annals of internal medicine.

[3]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[4]  K. Svärdsudd,et al.  Long-Term Glycemic Control Relates to Mortality in Type II Diabetes , 1995, Diabetes Care.

[5]  Charles M Peterson,et al.  Tests of glycemia in diabetes. , 1995, Diabetes care.

[6]  N. Wareham,et al.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.

[7]  A. Levey,et al.  Cardiovascular disease and chronic renal disease: a new paradigm. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.

[9]  M. Laakso,et al.  NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.

[10]  C. Marenah,et al.  Glycated Proteins as Indices of Glycaemic Control in Diabetic Patients with Chronic Renal Failure , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[11]  D. Singer,et al.  Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. , 1996, Journal of clinical epidemiology.

[12]  M. Akmal Hemodialysis in diabetic patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  S. Bowlin,et al.  Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. , 2004, Diabetes care.

[14]  M. Hanefeld,et al.  Postprandial glucose regulation and diabetic complications. , 2004, Archives of internal medicine.

[15]  E G Lowrie,et al.  Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  D. Goldstein,et al.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.

[17]  G. Chertow,et al.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.

[18]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[19]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.

[20]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[21]  M. Engelgau,et al.  The Evolving Diabetes Burden in the United States , 2004, Annals of Internal Medicine.

[22]  T. Shoji,et al.  Glycemic control is a predictor of survival for diabetic patients on hemodialysis. , 2001, Diabetes care.

[23]  P. Diem,et al.  [What you always wanted to know about HbA1c]. , 2000, Schweizerische medizinische Wochenschrift.

[24]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[25]  K. Malmberg Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus , 1997, BMJ.

[26]  D. Goldsmith,et al.  Assessing glycemic control in patients with diabetes and end-stage renal failure. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  M. Hanefeld,et al.  Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up , 1996, Diabetologia.

[28]  Neil R. Powe,et al.  Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.

[29]  W. Cefalu,et al.  Long-term glycemic control measurements in diabetic patients receiving hemodialysis. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  E. Friedman,et al.  Interdialytic weight gain correlates with glycosylated hemoglobin in diabetic hemodialysis patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  A. Agrawal,et al.  Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? , 2002, Clinical chemistry.

[32]  E. Eschwège,et al.  Evaluation of risk factors for development of complications in Type II diabetes in Europe , 2002, Diabetologia.

[33]  M. Feinglos,et al.  Emerging care for type 2 diabetes: using insulin to reach lower glycemic goals. , 2005, Cleveland Clinic journal of medicine.

[34]  A. Folsom,et al.  Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. , 2005, Archives of internal medicine.

[35]  C. Manske Hyperglycemia and intensive glycemic control in diabetic patients with chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  L. Sheiner,et al.  A pharmacodynamic model of erythropoietin therapy for uremic anemia , 1992, Clinical pharmacology and therapeutics.

[37]  G. Beck,et al.  Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.

[38]  T. Nakao,et al.  Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. , 1998, Internal medicine.

[39]  A. Collins,et al.  Chronic kidney disease and cardiovascular disease in the Medicare population. , 2003, Kidney international. Supplement.

[40]  S. Haffner,et al.  Effects of Diabetes and Level of Glycemia on All-Cause and Cardiovascular Mortality: The San Antonio Heart Study , 1998, Diabetes Care.

[41]  M Hørder,et al.  Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. , 1990, The New England journal of medicine.

[42]  H. Makino,et al.  What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis? , 1996, Nihon Jinzo Gakkai shi.

[43]  R. Mak Impact of End‐Stage Renal Disease and Dialysis on Glycemic Control , 2000, Seminars in dialysis.

[44]  G. Biesenbach,et al.  Long-Term Impact of Chronic Hemodialysis on Glycemic Control and Serum Lipids in Insulin-Treated Type 2-Diabetic Patients , 2005, Renal failure.

[45]  G. Murata,et al.  The Relationship Between Glycemic Control and Morbidity and Mortality for Diabetics on Dialysis , 1993, ASAIO journal.

[46]  Winfried März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005 .

[47]  P. Conlin,et al.  Development of evidence-based clinical practice guidelines for diabetes: the Department of Veterans Affairs/Department of Defense guidelines initiative. , 2004, Diabetes care.